Headlines

Assessing Eli Lilly: Insights From 7 Financial Analysts

Latest Ratings for LLY

Date Firm Action From To
Feb 2022 Morgan Stanley Maintains Overweight
Feb 2022 Mizuho Maintains Buy
Jan 2022 Morgan Stanley Maintains Overweight

View More Analyst Ratings for LLY

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *